JPRN-UMIN000004294已完成2 期
Endocrine effects of Toremifene(FARESTON®) and Leuprolide(LEUPLIN®) therapy in premenopausal breast cancer patients - Endocrine effects of Toremifene(FARESTON®) and Leuprolide(LEUPLIN®) therapy in premenopausal breast cancer patients
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- Female
入选标准
- 未提供
排除标准
- •1.Previous treatment for the breast cancer. 2.Inflammatory breast cancer or bilateral breast cancer. 3.Bilateral breast cancer 4.Active other malignancies 5.Past history of drug allergy or hypersensitivity. 6.QTc prolongation 7.Hypokalemia 8.Recieved with Class I or III anti-arrhythmia drugs 9.Judged inappropriate by physicians.
研究者
相似试验
招募中
2 期
Effect of High-dose Toremifene for premenopausal metastatic breast cancerpremenopausal metastatic breast cancerJPRN-UMIN000002867Multi Hormone Study Group25
已完成
2 期
High-Dose TOREMIFENE for non-steroidal AI failureRecurrent breast cancerJPRN-UMIN000003178Hiroshima Breast Cancer Study Group60
已完成
2 期
Evaluation of the effects of increasing tamoxifen dose on the treatment process in breast cancer patientsBreast cancer.Malignant neoplasm of breastIRCT2015082323734N1Isfahan University of Medical Siences100
进行中（未招募）
不适用
The impact of steroid hormones on symptom provocation in patients with premenstrual dysphoric disorder.Premenstrual Dysphoric DisorderEUCTR2004-004516-22-SEppsala University30
已完成
2 期
Toremifene in Treating Patients With Desmoid TumorsDesmoid TumorNCT00002595Advocate Lutheran General Hospital72